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1. Introduction 
Classical immunoassay methods are based on the 
displacement of a labelled antigen by the antigen to 
be measured from sites on an antibody and necessitate 
the separation of the free and bound antigen frac- 
tions. 
The fluorescence polarization method detects 
variations in the hydrodynamic volumes of fluores- 
cent molecules; the larger the molecule, the greater 
the increase in the degree of polarized light emitted. 
This permits interactions between a fluorescent 
antigen and an antibody to be detected directly, 
without recourse to a separation step. 
In the presence of a specific antiserum the antigen, 
labelled with a fluorochrome, is bound, resulting in 
an increase in the degree of fluorescence polariza- 
tion. Upon addition of unlabelled antigen, bound 
labelled antigen will be displaced from the antibody 
and the fluorescence polarization will decrease 
accordingly. 
This article describes the application of such a 
method to the measurement of human chorionic 
gonadotrophin. 
2. Materials and methods 
‘Pregnyl’ HCG, Organon (Oss, Holland) was used 
and measured using the ‘RIA HCG K1’, double anti- 
Abbreviations: HCG, human chorionic gonadotrophin; RIA, 
radio immuno assay; FITC, fluorescein isothiocyanate 
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body kit from the ‘Centre d’Energie Atomique’ 
(Gif-sur-Yvette, France) by the method in [ 11. Con- 
trol clinical assays of urinary HCG were performed 
using the haemagglutination inhibition method with 
the ‘Organon’ kit (Oss, Holland). 
Complete Freund’s adjuvant (Perrin’s modifica- 
tion) came from Calbiochem (San Diego, Calif.) and 
Biogel P2, P60 from Biorad Laboratories (Richmond, 
Calif.). 
Fluorescein isothiocyanate from Aldrich-Europe 
(Beerse, Belgium) was measured in solution, at pH 8, 
from itsAJ9s nm value, EM 1 cm = 8.52 X lo4 [2]. 
Other chemicals were ‘pro-analysis’ grade from 
Merck (Darmstadt). 
Optical densities were determined using a 
Perkin-Elmer Model 402 spectrophotometer, and 
fluorescence intensities with a FICA Model 55 MK 
II absolute differential spectrofluorimeter 
(Le Mesnil Saint-Denis). 
For the determination of the degree of fluores- 
cence polarization: 
Fll- Fl p=---- 
FII + FL 
(1) 
the fluorescence intensity of the sample was mea- 
sured when the polarizers for exciting and emitted 
light were parallel (FII) and perpendicular (FL). A 
model 400 polarization fluorimeter (SLM Instru- 
ments, Urbana, Ill.) was used. The principle of 
operation of this type of instrument has been 
described [3,4]. This instrument allowed one to 
obtain the ratio Fll/Fl directly and averaged from 
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1 O-l 00 values. Each determination was carried out 
with two samples and each reading (which corre- 
sponds to a mean of 10 values) was taken 3 times. 
The cuvette was held at 4°C by circulating alcohol 
Haake model Fz K circulator; the contents being 
first passed through a millipore filter, 0.22 E.tm 
Millipore Filter Corp. (Bedford, Mass.). 
2.1, Atrijkation of HCG 
‘Pregnyl’ HCG, at -20 mg in 4.5 ml was first fil- 
tered on a 1.5 X 85 cm Biogel P2 (100-200 mesh) 
at 4°C using 0.1 M sodium phosphate buffer, pH 7.0. 
The excluded peak was submitted to analytical 
polyacrylamide gel electrophoresis (8% acrylamide, 
0.4% bis-acrylamide) with 0.02 M Tris-glycine 
buffer, pH 8.6, and one major band was found with 
two minor rapidly migrating bands. 
After a 1 O-fold concentration of the excluded 
peak and dialysis against 110.05 M sodium phosphate 
buffer, pH 7.0, at 4’C, an 0.8 ml sample of HCG 
0.5. 
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Fig.2. Polyacrylamide gel electrophoresis of HCG before 
(A) and after (B) filtration on Biogel P60. 
(4.8 mg/ml) was filtered on a 1 .I X 30 cm Biogel P60 
(100-200 mesh) column as in [ 51. 
Figure 1 shows the elution profile from this column; 
the protein fraction corresponding to the 11-14 ml 
elution volume, was submitted to gel electrophoresis 
as above (fig.2) and showed the removal of the 2 minor 
rapidly migrating bands by the gel filtration; the 
remaining band was comparable to that given by 
highly-purified HCG preparations [5--71. 
Fig.1. Gel fdtration of partially purified HCG (3.8 mg in 
0.8 ml) on a 1.1 X 30 cm column of Biogel P60 (loo-200 
mesh) with 0.05 M sodium phosphate buffer, pH 7.0; the 
fraction eluted between 11 ml and 14 ml contained electro- 
phoretically pure HCG. 
5.5 
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2.2. Raising and titer determination of antisera 
Anti HCG antisera were raised in ‘Fauve de 
Bourgogne’ rabbits after intradermal injection, at 
about 20 sites in the dorsal region, according to [8], 
of an emulsion containing 1 mg HCG in physiological 
saline and 0.6 ml complete Freund’s adjuvant; after 
4 booster injections, at 4-5 week intervals, the immu- 
nosera were collected and stored in small fractions 
at -15°C. 
The titers of 3 antisera (ALr, AL, ALa) were 
determined by RIA in the presence of 2 ng HCG, 
20 nCi radioactive tracer HCG (from the CEA HCG 
Kr kit) and 0.05 M phosphate buffer, pH 7.5, with 
final vol. 0.4 ml. The dilutions of these antisera bind- 
ing 50% of the antigen (2 ng) in this volume are shown 
in table 1. 
3. Results and discussion 
The unionised lysine x amino groups of the HCG 
were carbamylated with fluorescein isothiocyanate 
(FITC) by the modified method in [9]. The HCG was 
dialysed for 24 h against 2% sodium hydrogen carbo- 
nate, pH 8.5 at 4’C. To label protein in a 2 : 1 (FITC/ 
HCG) ratio, 10 ~1 freshly prepared solution of FITC 
in acetone (19 mg/ml) was added slowly, to 1 ml 
HCG solution (7 mg/ml) at 4°C with gentle agitation. 
After 18-20 h at 4°C the unreacted fluorochrome 
was removed by filtration of the sample on a 
1.5 X 60 cm Biogel P2 column, using 0.1 M sodium 
phosphate buffer, pH 7.0; the excluded peak being 
collected. 
The degree of labelling was estimated by measure- 
ment of protein concentration using the Lowry 
method [lo]; the molecular weight of HCG being 
taken as 37 900 [ 1 l] and by absorbance measurement 
Table 1 
The titer (50% binding) of 3 rabbit antisera with 
20 nCi HCG (2 ng) 
Antisera 
AL, 
AL, 
AL, 
Reaction vol. 0.4 ml 
Final dilution 
l/12 000 
l/36 000 
l/14 000 
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of FITC, taking into account an -15% decrease in 
absorbance by protein-reacted FITC [ 12,131. Under 
these conditions it was found that an average of 1.2 
molecules of FITC had reacted with 1 molecule of 
HCG, and the complex retained 70% initial immunol- 
ogy activity (RIA determination). 
3.1. Dilution curve for the antiserum using ji’uores- 
cence polarization 
Samples of HCG-FITC, at final cont. 1 pg/ml 
were incubated for 3 h at 4°C with various dilutions 
of antiserum Ah in 0.1 M sodium phosphate buffer, 
pH 7.0, final vol. 2.0 ml. Figure 3 shows the increase 
in the amount of fluorescence polarization as a func- 
tion of the concentration of the antiserum; 5% 
binding is found for the antiserum ALa at 0.25 
mg/ml (final dilution l/200). This result is in agree- 
ment with that observed in the determination titer 
by RIA (given that the HCG concentration in this 
experiment is 200 times greater than that used for 
the titer determination by RIA). 
3.2. Immunoassay 
Figure 4 shows the competition between increas- 
ing amounts of non fluorescent HCG (0.27-64 pg/ml) 
and a constant amount of HCG-FITC (1 I.cg/ml) 
with a constant amount of antiserum 0.65 mg/ml 
(final dilution l/75) after incubation for 2 h at 4°C 
in 0.1 M sodium phosphate buffer, pH 7.0, final vol. 
Fig.3. Dilution curve for the binding of HCG-FITC by 
antisera AL, showing the increase in fluorescence polariza- 
tion as a function of the antiserum added. HCG-FITC 
(1 rg/ml and antiserum were equilibrated 2 h at 4°C in 
0.1 M phosphate buffer, pH 7.0, with final vol. 2.0 ml 
before measurement of fluorescence polarization. 
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2.0 ml. The competition was followed directly by 
reading the polarization of fluorescence. If we take 
the value of polarization with HCG to be 0.297 
corresponding to 0% binding and the value of 0.345 
corresponding to 100% binding, a maximum displace- 
ment of 70% is found under these conditions. 
It can be seen that the displacement curve has a 
slope such that it can be used for the measurement 
of between 0.50 pg and 10 Erg/ml HCG (3.3-66 
N/ml) and thus for the estimation of urinary HCG 
levels. 
3.3. Clinical applications 
Urine from pregnant women (6-10 weeks) and 
from women presenting a chorio-epithelioma or a 
molar pregnancy, were dialysed against bi-distilled 
water at 4’C and filtered through a 0.22 I.tm millipore 
filter. Quantities of 0.1,0.2 and 0.6 ml were intro- 
duced into reaction media containing HCG-FITC 
Fig.4. Displacement curve showing the decrease. in fluores- 
cence polarization of a solution of HCG-FITC (1 pg/mI 
assay mixture) and antiserum AL, (final dihrtion l/75) 
caused by increasing amounts of standard HCG (0.27-64 
Gg/ml assay mixture). Tubes were equilibrated for 2 h at 
4°C in phosphate buffer pH 7.0 with final vol. 2.0 ml, 
before measurement of fluorescence polarization. 
and antibody such that final concentrations in 2 ml, 
were as described above. 
The values obtained for fluorescence polarization 
were compared with a standard curve for 0.50-l 0 Erg 
(3.3-66 IU) HCG. 
Table 2 compares the levels of HCG (in IU) 
Table 2 
Urinary levels of HCG (III/24 h) as measured by fluorescence polarization 
immunoassay and by haemagghrtination i hibition assay for 7 clinical cases 
Urine sample 
(ml) 
Fluorescence 
polarization 
immunoassay 
Haemagglutination 
inhibition assay 
Pregnancy 0.1 31 000 20 000-100 000 
(6 -7 weeks) 0.25 15 000 
Pregnancy 0.5 18 000 10 ooo- 50 000 
(6-7 weeks) 1.0 10 000 
Pregnancy 0.2 131000 100 000-200 000 
(10 weeks) 0.4 112 000 
Pregnancy 0.2 125 000 100 000-200 000 
(11 weeks) 0.4 8.5 000 
Molar pregnancy 0.5 53 000 20 ooo- 50 000 
1.0 45 000 
EpitheIioma 0.1 327 500 > 200 000 
0.2 201 000 
Pregnancy? 1 640 < 1000 
1.5 760 
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obtained by fluorescence polarization and those 
obtained by haemagglutination inhibition. It may be 
noted that the values obtained for small urine samples 
are higher than for larger volumes. In cases of com- 
mencement of pregnancy it is possible to rapidly con- 
centrate urine samples to l/2-1 /3 volume by vacuum 
dialysis at 4°C. 
4. Conclusion 
The reference hormone used for the polarization 
of fluorescence assay was electrophoretically pure and 
stored in small fractions at -2O”C, remains stable for 
at least 1 year. 
The linkage of FITC to HCG diminishes the latter’s 
immunological reactivity by 30%, but analytical 
electrophoresis of the protein before and after label- 
ling showed it retained its native character. The excita- 
tion and emission maxima of the fluorochrome are not 
modified and linkage with the protein is remarkably 
stable [ 141. The HCG-FITC has been found to be 
stable for at least 6 months at -20°C. 
Analogous difficulties have been found in obtaining 
antisera with both a high titer and a high specificity 
for a glycoprotein such HCG, presenting similarities 
with HLH and FSH, to those in [ 151. However, since 
the levels of HCG to be measured by this method 
were some 700~times higher than those of the latter 
hormones, the titer obtained appears sufficient for 
urinary HCG measurement and the specificity seemed 
to be of secondary importance [ 16 1. 
Direct agreement was found between results 
obtained by polarization of fluorescence and by 
haemagglutination inhibition, and moreover the 
polarization of fluorescence method is reliable and 
rapid. After millipore filtration, an incubation period 
of 2 h at 4°C is followed immediately by direct reading 
of the percentages of free and bound HCG without 
recourse to a separation step. For highly coloured 
urines, found particularly when the urinary volume 
is small, a dialysis against distilled water before milli- 
pore filtration is recommended. 
The sensitivity of the method is only 2 IU/ml, but 
its rapidity shows it to be useful not only for HCG 
determination during pregnancy, but also for urgently 
required determinations in certain pathological cases, 
such as the hydatiform mole or choriocarcinoma; 
such determinations being of increasing clinical inter- 
est [17,18]. 
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